NCT04276207View on ClinicalTrials.gov

A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 25, 2020

Primary Completion Date

August 10, 2020

Study Completion Date

August 10, 2020

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

LY900014

Administered by CSII

DRUG

Insulin Lispro

Administered by CSII

Trial Locations (1)

55116

Profil Mainz GmbH & Co. KG, Mainz

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04276207 - A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps | Biotech Hunter | Biotech Hunter